Preventive Medicine Report
: Analysis on the Market, Trends, and TechnologiesThe preventive medicine sector has achieved a 42.33% annual growth in funding rounds, with companies raising a cumulative $39.57 billion over recent years. At the same time, the global market was valued at USD 417.3 billion in 2024, driven by rising chronic disease prevalence and digital health innovations (Preventive Medicine Market Outlook 2025 to 2035). These dynamics underscore the shift from reactive to proactive care and highlight significant investment momentum in early-detection, personalized risk stratification, and remote monitoring solutions.
The last time we updated this report was 13 days ago. If there’s something missing or off, your tips are welcome!
Topic Dominance Index of Preventive Medicine
The Dominance Index for Preventive Medicine merges timelines of published articles, newly founded companies, and global search data to provide a comprehensive perspective into the topic.
Key Activities and Applications
- Early detection and screening of asymptomatic conditions through mobile and point-of-care diagnostics (Preventive Healthcare Technologies and Services Market).
- Personalized risk stratification and tailored intervention planning using AI-driven biomarker analytics (2025 Preventive Healthcare Technologies And Services Market Dynamics: Comprehensive Analysis of Trends & Growth).
- Vaccination and immunization program management supporting population-level prophylaxis.
- Digital wellness platforms integrating behavior modification, lifestyle coaching, and compliance tracking (Preventive Healthcare Technologies And Services Market).
- Corporate and insurance-driven value-based care models embedding preventive services into benefit designs.
Emergent Trends and Core Insights
- Chronic disease burden remains the primary market driver, with diabetes, cardiovascular disorders, and cancer catalyzing demand for prevention solutions.
- AI and predictive analytics are enhancing early-stage disease identification and personalized intervention efficacy.
- Remote and virtual care delivery models are expanding access, growing at a 14.52% CAGR from 2025 to 2030 (Preventive Healthcare Technologies And Services Market).
- Asia-Pacific is the fastest-growing region (14.19% CAGR), driven by rising incomes, government digital-health initiatives, and expanding telehealth infrastructure.
- Data privacy and cybersecurity concerns threaten to shave off up to 1.5 percentage points of growth by increasing compliance costs.
- Personalized preventive medicine is gaining traction, with company counts up 171.15% over five years and funding rounds growing 108.71% annually.
Technologies and Methodologies
- Machine learning and multi-omic biomarker platforms for individual risk profiling.
- Mobile-based AI screening transforming smartphones into diagnostic tools across 50+ clinical domains.
- Wearable and IoT-enabled sensors enabling continuous vital sign monitoring and anomaly detection.
- Telehealth and remote patient management systems integrating clinical decision support for proactive intervention.
- Advanced immuno-assays and AI-powered blood tests for early cardiovascular risk detection (Preventive and Therapeutic Vaccine Market Size, Industry Analysis Report, Regional Outlook, Application Growth Potential, Competitive Market Growth & Forecast, 2024 – 2032).
Preventive Medicine Funding
A total of 1.1K Preventive Medicine companies have received funding.
Overall, Preventive Medicine companies have raised $36.1B.
Companies within the Preventive Medicine domain have secured capital from 3.5K funding rounds.
The chart shows the funding trendline of Preventive Medicine companies over the last 5 years
Preventive Medicine Companies
- Livez: Pioneers “Autonomous Prevention” with a mobile app that conducts AI-based screenings across 50+ domains, links members to on-demand vaccines and screenings, and targets 85% early disease detection to reduce 75% of claims.
- Prevencio: Develops AI-powered multi-proteomic blood tests for cardiovascular risk, offering seven FDA-validated assays that outperform standard stress tests, driving earlier intervention and reducing unnecessary procedures.
- Prediscan Medtech: Uses deep learning to non-invasively predict kidney, liver, and heart diseases through retinal imaging, enabling proactive care and treatment prioritization at the earliest stages.
- PreventScripts: Offers a digital primary-care platform that identifies at-risk patients, delivers reimbursable preventive care plans, and drives behavior change through science-backed monitoring tools.
Delve into the corporate landscape of Preventive Medicine with TrendFeedr’s Companies tool
7.8K Preventive Medicine Companies
Discover Preventive Medicine Companies, their Funding, Manpower, Revenues, Stages, and much more
Preventive Medicine Investors
TrendFeedr’s Investors tool provides insights into 3.6K Preventive Medicine investors for you to keep ahead of the curve. This resource is critical for analyzing investment activities, funding trends, and market potential within the Preventive Medicine industry.
3.6K Preventive Medicine Investors
Discover Preventive Medicine Investors, Funding Rounds, Invested Amounts, and Funding Growth
Preventive Medicine News
TrendFeedr’s News feature offers you access to 10.8K articles on Preventive Medicine. Stay informed about the latest trends, technologies, and market shifts to enhance your strategic planning and decision-making.
10.8K Preventive Medicine News Articles
Discover Latest Preventive Medicine Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
Preventive medicine is transitioning healthcare toward earlier, data-driven intervention models that lower costs and improve outcomes. The convergence of AI, digital diagnostics, and remote care is catalyzing substantial funding, with an annual 42.33% increase in investment rounds. Market projections exceed USD 900 billion by the early 2030s, reflecting strong growth in screening technologies, personalized risk analytics, and telehealth. Strategic partnerships between tech innovators, payers, and providers will be critical to scaling preventive solutions and addressing barriers such as data security and regulatory compliance. As chronic disease prevalence continues to rise, stakeholders must prioritize integrated preventive strategies to capture value and enhance public health resilience.
Are you an insider in the trends or tech industry? We’d love for you to contribute to our content.
